Ezetimibe-associated adverse effects: wh
โ
M. Florentin; E. N. Liberopoulos; M. S. Elisaf
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 179 KB
## Objective: Ezetimibe is a relatively new lipid lowering agent, which is indicated for the treatment of primary hypercholesterolaemia, either as monotherapy or in combination with other hypolipidaemic drugs. the objective of the present article was to review the side effects attributed to ezetimi